Inizio Advisory

Medical Science Liaisons (MSLs) are evolving — and so is their impact. How can MSLs shift from tactical execution to becoming true strategic partners? In this latest case study, learn how we helped an organization unlock deeper insights and improve cross-functional alignment—elevating the role of MSLs and driving greater impact across Medical Affairs. Read the full case study: https://lnkd.in/ehEkXwfR #MSL #MedicalAffairs #PharmaStrategy #LifeSciences

As the EU rolls out Joint Clinical Assessments (JCA) under the HTA Regulation, important lessons from the past are resurfacing. Our latest article explores the striking parallels with EMA’s expansion—where a handful of countries dominated assessments, leaving smaller Member States with limited influence. Without intervention, JCA risks repeating this pattern. To support a more balanced, effective implementation, our experts propose: ✅ Quotas and rotation for assessor roles ✅ Minimum participation in PICO surveys ✅ Capacity-building for smaller HTA bodies Read the full article by Clément François, Cecile Remuzat, and Shrividya Iyer, Ph.D here: https://lnkd.in/e_SDbnnY #HTA #JCA #MarketAccess #EUMarketAccess #HealthPolicy

Exciting news – two of our recent papers have been shortlisted for the 2025 EphMRA Awards! 🏆 Best Business Impact – "Insights to ensure successful launch of a rare disease asset" This project in collaboration with Otsuka Pharmaceutical Europe Ltd focused on supporting a successful launch of a product. Through robust research across multiple European markets, the team uncovered a greater than expected variety of physician specialty involvement, built a conjoint grounded in real-world insights, and laid the foundation for ongoing strategic development. Well done Helen Ansell, Julie Denny DipM ACIM and Elizabeth Thomson for leading the initiative and to the wider team Emilie Braund, Richard Newman, Oliver Walker, Shaun Callaghan, Gary Bright, and John Case for their impactful work and thanks to our Otsuka colleagues, Dr Allison Fleetwood and Phoebe Jones for their collaboration! 💡 Innovative Approach – "The persistence puzzle: Cracking the code of patient adherence" This fresh take on the complex challenge of non-adherence explored subconscious and cultural drivers influencing both patients and physicians. Using ethnographic methods and multidisciplinary expertise, the team delivered powerful, human-centered insights to address a long-standing issue in healthcare. Congratulations to Mandira Kar, Marc Yates, Amy Heneghan, Andressa Gusmon Da Silva, Annabel Robertson, and Paulina Dabrowska for their efforts on this innovative approach! We’re proud to see both projects recognized for their creativity, depth, and real-world impact. #EphMRA #MarketResearch #Innovation #BusinessImpact #Teamwork

The role of Medical Science Liaisons (MSLs) is evolving—fast. But what does it take for MSLs to move from tactical execution to truly strategic influence? In STEM's latest case study, discover how one organization redefined the MSL function by unlocking richer insights and enhancing cross-functional alignment—ultimately driving greater value across Medical Affairs. Explore how MSLs can become key strategic partners here: https://lnkd.in/ed7kaPZy #MSL #MedicalAffairs #PharmaStrategy #LifeSciences

We’re proud to share the Vynamic 2024 DEI Annual Report, showcasing our continued commitment to building a culture where everyone feels seen, heard, and valued. From expanding inclusive leadership and advancing DEI education, to partnering with communities and supporting clients in driving health equity—this past year was all about turning education into action. 💡 Highlights include: • 750+ volunteer hours across 22 global nonprofits • A 100/100 on the HRC Corporate Equality Index • Continued investment in ERGs, inclusive policy, and community impact • DEI-driven client strategies that improve patient outcomes We believe there is a better way—and we’re building it together. Read the full report here: https://lnkd.in/gKRxUYfe #DEI #Belonging #HealthEquity

What do the experts say about AI’s role in healthcare? From smarter decision-making to accelerated drug development, leaders across the industry agree: The future of healthcare depends on the power of AI and human expertise. Want the full picture? Download the full report for deeper insights on how AI and audience intelligence are reshaping strategy, speed, and scale in healthcare: https://lnkd.in/ekmw69fH Mary-Kate McGarry, Jamie Avallone, Thomas Mueller, Ph.D., Remco op den Kelder, Anthony Haywood #ReimagineHealth #AI #ArtificalIntelligence #Pharma #Healthcare

From complex questions to confident decisions, ClarityNav, part of InizioNavigator, helps guide the way. We work at the intersection of insight, impact, and innovation—partnering with clients to design bold strategies and drive real-world results. Our team brings deep expertise, strategic thinking, and a collaborative mindset to help life sciences leaders navigate uncertainty and uncover opportunity. 🎥 Get a glimpse into how we help clients #ElevateMedicalAffairs and visit our website to learn more: https://lnkd.in/eFkEFc-r #MedicalAffairs #ClarityNav #Innovation #Strategy #Insight

The life sciences industry is constantly evolving, making it essential for your product launch to have a well-defined strategy and meticulous plan, early. Our latest guidebook provides expert insights, tools, and real-world guidance to help pharma companies navigate their launch journeys with certainty. This guide will help you: ✅ Understand your market ✅ Optimize your launch plan ✅ Validate your strategy with confidence Download the guide here: https://lnkd.in/eJUbWvxw #ProductLaunch #LifeSciences #PharmaLaunch #CommercialStrategy

We are excited to announce that Timothy Luxford, is STEM’s new Chief Commercial Officer (CCO). Through his near decade tenure with STEM, Tim has played a pivotal role in shaping our organization, both across European markets and more globally. He has moved through various leadership positions including Project Director, Country Manager, Head of International Operations, Europe Regional Leader, and most recently, President of Europe and Emerging Markets. Tim’s experience will continue to be critical in supporting our teams and clients to accelerate brand performance and build on success to drive the future of our business. Please join us in congratulating Tim! As Tim steps into the role, Daniel Parker, former Chief Commercial Officer, transitions to a Global Commercial role within Inizio. STEM extends its sincere thanks to Dan for his impactful leadership and dedication throughout his tenure. Congratulations, Dan, and best wishes for continued success in this new chapter. #LeadershipUpdate #FirmNews

Our Vynamic team members, Buck Thompson and Karen Schoener Baldry had the chance to join other industry leaders at Reuters Events Pharma USA 2025 last week. From AI and innovation to patient engagement and market access, our leaders are walking away with new insights. We're looking forward to further involvement at other Reuters events later this year. If you didn't get a chance to meet with us, contact us here: https://lnkd.in/dSKNz5Ay #ReutersPharmaUSA2025 #PharmaInnovation #FutureOfPharma #HealthcareLeadership #Collaboration #Philadelphia